Selected research
Industry Research
Inhaled Nitric Oxide Delivery Device Industry Research Report 2026
Market perspective
The global Inhaled Nitric Oxide Delivery Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhaled Nitric Oxide Delivery Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inhaled Nitric Oxide Delivery Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhaled Nitric Oxide Delivery Device include Air Liquide Healthcare, Bellerophon Therapeutics, Beyond Air, Circassia Pharmaceuticals, Getinge, LINDE, Mallinckrodt Pharmaceuticals, NU MED and Praxair Technology Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhaled Nitric Oxide Delivery Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhaled Nitric Oxide Delivery Device Market by Company
Air Liquide Healthcare
Bellerophon Therapeutics
Beyond Air
Circassia Pharmaceuticals
Getinge
LINDE
Mallinckrodt Pharmaceuticals
NU MED
Praxair Technology Inc.
Vero Biotech
Inhaled Nitric Oxide Delivery Device Segment by Type
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Inhaled Nitric Oxide Delivery Device Segment by Application
Hypoxic Respiratory Failure (HRF)
Chronic Obstructive Pulmonary Disease (COPD)
Acute Hypoxemic Respiratory Failure (AHRF)
Others
Inhaled Nitric Oxide Delivery Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Delivery Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhaled Nitric Oxide Delivery Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhaled Nitric Oxide Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inhaled Nitric Oxide Delivery Device for Children
- Inhaled Nitric Oxide Delivery Device for Adults
Applications
- Hypoxic Respiratory Failure (HRF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Hypoxemic Respiratory Failure (AHRF)
- Others
Companies covered
- Air Liquide Healthcare
- Bellerophon Therapeutics
- Beyond Air
- Circassia Pharmaceuticals
- Getinge
- LINDE
- Mallinckrodt Pharmaceuticals
- NU MED
- Praxair Technology Inc.
- Vero Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inhaled Nitric Oxide Delivery Device Market Size (2021-2032)
- 2.2.2 Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032)
- 2.2.3 Global Inhaled Nitric Oxide Delivery Device Market Average Price (2021-2032)
- 2.3 Inhaled Nitric Oxide Delivery Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inhaled Nitric Oxide Delivery Device for Children
- 2.3.3 Inhaled Nitric Oxide Delivery Device for Adults
- 2.4 Inhaled Nitric Oxide Delivery Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hypoxic Respiratory Failure (HRF)
- 2.4.3 Chronic Obstructive Pulmonary Disease (COPD)
- 2.4.4 Acute Hypoxemic Respiratory Failure (AHRF)
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inhaled Nitric Oxide Delivery Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inhaled Nitric Oxide Delivery Device Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Inhaled Nitric Oxide Delivery Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Inhaled Nitric Oxide Delivery Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Inhaled Nitric Oxide Delivery Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Product Type & Application
- 3.8 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Established Date
- 3.9 Global Inhaled Nitric Oxide Delivery Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Air Liquide Healthcare
- 4.1.1 Air Liquide Healthcare Company Information
- 4.1.2 Air Liquide Healthcare Business Overview
- 4.1.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.1.5 Air Liquide Healthcare Recent Developments
- 4.2 Bellerophon Therapeutics
- 4.2.1 Bellerophon Therapeutics Company Information
- 4.2.2 Bellerophon Therapeutics Business Overview
- 4.2.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.2.5 Bellerophon Therapeutics Recent Developments
- 4.3 Beyond Air
- 4.3.1 Beyond Air Company Information
- 4.3.2 Beyond Air Business Overview
- 4.3.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.3.5 Beyond Air Recent Developments
- 4.4 Circassia Pharmaceuticals
- 4.4.1 Circassia Pharmaceuticals Company Information
- 4.4.2 Circassia Pharmaceuticals Business Overview
- 4.4.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.4.5 Circassia Pharmaceuticals Recent Developments
- 4.5 Getinge
- 4.5.1 Getinge Company Information
- 4.5.2 Getinge Business Overview
- 4.5.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.5.5 Getinge Recent Developments
- 4.6 LINDE
- 4.6.1 LINDE Company Information
- 4.6.2 LINDE Business Overview
- 4.6.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.6.5 LINDE Recent Developments
- 4.7 Mallinckrodt Pharmaceuticals
- 4.7.1 Mallinckrodt Pharmaceuticals Company Information
- 4.7.2 Mallinckrodt Pharmaceuticals Business Overview
- 4.7.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.7.5 Mallinckrodt Pharmaceuticals Recent Developments
- 4.8 NU MED
- 4.8.1 NU MED Company Information
- 4.8.2 NU MED Business Overview
- 4.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.8.5 NU MED Recent Developments
- 4.9 Praxair Technology Inc.
- 4.9.1 Praxair Technology Inc. Company Information
- 4.9.2 Praxair Technology Inc. Business Overview
- 4.9.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.9.5 Praxair Technology Inc. Recent Developments
- 4.10 Vero Biotech
- 4.10.1 Vero Biotech Company Information
- 4.10.2 Vero Biotech Business Overview
- 4.10.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
- 4.10.5 Vero Biotech Recent Developments
5 Global Inhaled Nitric Oxide Delivery Device Market Scenario by Region
- 5.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021-2032
- 5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021-2026
- 5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2027-2032
- 5.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021-2032
- 5.3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021-2026
- 5.3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2027-2032
- 5.4 North America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
- 5.4.1 North America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
- 5.4.3 North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
- 5.5.1 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
- 5.5.3 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
- 5.7.1 South America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
- 5.7.3 South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
- 6.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032)
- 6.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
- 6.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
- 7.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032)
- 7.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
- 7.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inhaled Nitric Oxide Delivery Device Value Chain Analysis
- 8.1.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inhaled Nitric Oxide Delivery Device Production Mode & Process
- 8.2 Inhaled Nitric Oxide Delivery Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inhaled Nitric Oxide Delivery Device Distributors
- 8.2.3 Inhaled Nitric Oxide Delivery Device Customers
9 Global Inhaled Nitric Oxide Delivery Device Analyzing Market Dynamics
- 9.1 Inhaled Nitric Oxide Delivery Device Industry Trends
- 9.2 Inhaled Nitric Oxide Delivery Device Industry Drivers
- 9.3 Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
- 9.4 Inhaled Nitric Oxide Delivery Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst